The post MRI Scans and Hidden Risks: What You Need to Know About Gadolinium and Oxalic Acid appeared first on .
]]>Gadolinium-based contrast agents (GBCAs) are widely used to improve the visibility of internal organs and tissues during MRI scans. While generally considered safe, gadolinium is inherently toxic in its free form. To mitigate this, it’s administered in a chelated form, bound to other molecules that help reduce toxicity. However, the University of New Mexico study found that oxalic acid can cause gadolinium to separate from its chelating agents. This reaction can lead to the formation of nanoparticles that may infiltrate and persist in various organs.
Oxalic acid is naturally present in many foods, including spinach, beets, nuts, and berries. It’s also produced in the body during the metabolism of vitamin C. While generally harmless, oxalic acid’s ability to bind with metals like calcium—and now, potentially gadolinium—can result in the formation of insoluble compounds. In the case of gadolinium, this may mean the creation of persistent nanoparticles that stay in the body, raising concerns about long-term effects.
The accumulation of gadolinium nanoparticles in the body has been linked to a range of health issues, particularly for those with impaired kidney function. One known condition is nephrogenic systemic fibrosis (NSF), a rare but serious disease that causes skin thickening and joint stiffness. Even in people with normal kidney function, the long-term implications of gadolinium retention remain unclear. This uncertainty has prompted experts to recommend more research and a cautious approach to the use of GBCAs in imaging procedures.
MRI scans remain an invaluable tool in diagnosing a wide range of conditions, and gadolinium-based contrast agents have significantly improved their precision. But new findings, like the ones from the University of New Mexico, suggest that we may need to look more closely at the long-term effects of these injections—especially when dietary compounds like oxalic acid could be a hidden variable. With awareness, open communication with healthcare providers, and thoughtful decision-making, patients can benefit from advanced diagnostics while minimizing potential risks.
The post MRI Scans and Hidden Risks: What You Need to Know About Gadolinium and Oxalic Acid appeared first on .
]]>The post MRI Scans and Hidden Risks: What You Need to Know About Gadolinium and Oxalic Acid appeared first on .
]]>Gadolinium-based contrast agents (GBCAs) are widely used to improve the visibility of internal organs and tissues during MRI scans. While generally considered safe, gadolinium is inherently toxic in its free form. To mitigate this, it’s administered in a chelated form, bound to other molecules that help reduce toxicity. However, the University of New Mexico study found that oxalic acid can cause gadolinium to separate from its chelating agents. This reaction can lead to the formation of nanoparticles that may infiltrate and persist in various organs.
Oxalic acid is naturally present in many foods, including spinach, beets, nuts, and berries. It’s also produced in the body during the metabolism of vitamin C. While generally harmless, oxalic acid’s ability to bind with metals like calcium—and now, potentially gadolinium—can result in the formation of insoluble compounds. In the case of gadolinium, this may mean the creation of persistent nanoparticles that stay in the body, raising concerns about long-term effects.
The accumulation of gadolinium nanoparticles in the body has been linked to a range of health issues, particularly for those with impaired kidney function. One known condition is nephrogenic systemic fibrosis (NSF), a rare but serious disease that causes skin thickening and joint stiffness. Even in people with normal kidney function, the long-term implications of gadolinium retention remain unclear. This uncertainty has prompted experts to recommend more research and a cautious approach to the use of GBCAs in imaging procedures.
MRI scans remain an invaluable tool in diagnosing a wide range of conditions, and gadolinium-based contrast agents have significantly improved their precision. But new findings, like the ones from the University of New Mexico, suggest that we may need to look more closely at the long-term effects of these injections—especially when dietary compounds like oxalic acid could be a hidden variable. With awareness, open communication with healthcare providers, and thoughtful decision-making, patients can benefit from advanced diagnostics while minimizing potential risks.
The post MRI Scans and Hidden Risks: What You Need to Know About Gadolinium and Oxalic Acid appeared first on .
]]>